{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:21:41Z","timestamp":1780316501537,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.hfc.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T11:27:29Z","timestamp":1306150049000},"page":"195-205","source":"Crossref","is-referenced-by-count":9,"title":["Role of Antiarrhythmic Drugs: Frequent Implantable Cardioverter-Defibrillator Shocks, Risk of Proarrhythmia, and New Drug Therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Christopher","family":"Droogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan-Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2010.12.003_bib1","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMra035432","article-title":"Implantable cardioverter-defibrillators","volume":"349","author":"DiMarco","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl\u00a01","key":"10.1016\/j.hfc.2010.12.003_bib2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1177\/10742484050100i406","article-title":"Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era","volume":"10","author":"Reiffel","year":"2005","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hfc.2010.12.003_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198008073030607","article-title":"Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings","volume":"303","author":"Mirowski","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib4","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCUALTIONAHA.108.189742","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9149(02)03008-4","article-title":"Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000","volume":"91","author":"Al-Khatib","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.1989.00390070064007","article-title":"Outpatient antiarrhythmic drug use from 1970 through 1986","volume":"149","author":"Hine","year":"1989","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2010.12.003_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11606-007-0392-0","article-title":"Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis","volume":"23","author":"Zhan","year":"2008","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/CIRCEP.109.893628","article-title":"Should catheter ablation be the preferred therapy for reducing ICD shocks?: ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy","volume":"2","author":"Patel","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.hrthm.2004.07.017","article-title":"Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator","volume":"1","author":"Dorian","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2010.12.003_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-8703(00)90010-3","article-title":"Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators","volume":"139","author":"Nanthakumar","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2010.12.003_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.CIR.98.7.663","article-title":"Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators","volume":"98","author":"Rosenqvist","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1540-8159.2000.tb00877.x","article-title":"Patients\u2019 attitudes toward implanted defibrillator shocks","volume":"23","author":"Ahmad","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1440-172x.2002.00345.x","article-title":"Australian implantable cardiac defibrillator recipients: quality-of-life issues","volume":"8","author":"Pelletier","year":"2002","journal-title":"Int J Nurs Pract"},{"key":"10.1016\/j.hfc.2010.12.003_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0147-9563(05)80071-8","article-title":"Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator","volume":"24","author":"Dougherty","year":"1995","journal-title":"Heart Lung"},{"key":"10.1016\/j.hfc.2010.12.003_bib15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1540-8159.1998.tb00179.x","article-title":"Psychosocial outcome after ICD implantation: a current perspective","volume":"21","author":"Heller","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4065\/80.2.232","article-title":"Implantable cardioverter-defibrillators, induced anxiety, and quality of life","volume":"80","author":"Sola","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2010.12.003_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9149(96)00454-7","article-title":"Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy","volume":"78","author":"Greene","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib18","doi-asserted-by":"crossref","first-page":"41I","DOI":"10.1016\/S0002-9149(98)00471-8","article-title":"Interactions between implantable cardioverter-defibrillators and class III agents","volume":"82","author":"Movsowitz","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mhj.2001.117129","article-title":"Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study","volume":"142","author":"Steinberg","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2010.12.003_bib20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d, l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0735-1097(98)00521-X","article-title":"Suppression of sustained ventricular tachyarrhythmias: a comparison of d, l-sotalol with no antiarrhythmic drug treatment","volume":"33","author":"Kuhlkamp","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib22","first-page":"I","article-title":"Efficacy and safety of oral dofetilide in patients with an implantable defibrillator: a multi-center study","volume":"100","author":"O\u2019Toole","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1460-9592.2002.01571.x","article-title":"Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"25","author":"Kettering","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0002-9149(98)00478-0","article-title":"Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter\/defibrillator","volume":"82","author":"Seidl","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9149(01)01973-7","article-title":"Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation","volume":"88","author":"Connolly","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacc.2003.07.033","article-title":"Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators","volume":"43","author":"Singer","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib27","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1161\/01.CIR.0000149240.98971.A8","article-title":"Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"110","author":"Dorian","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2008.05.055","article-title":"Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial","volume":"52","author":"Dorian","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2010.12.003_bib30","unstructured":"Kowey PR, Singh BN. Dronedarone in patients with implantable defibrillators. Heart Rhythm 2004: 25th Annual Scientific Sessions of the Heart Rhythm Society, late-breaking clinical trials oral presentation, San Francisco (CA), May 19\u201322, 2004."},{"key":"10.1016\/j.hfc.2010.12.003_bib31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0300-9572(00)00206-9","article-title":"Combination ICD and drug treatments-best options","volume":"45","author":"Dorian","year":"2000","journal-title":"Resuscitation"},{"key":"10.1016\/j.hfc.2010.12.003_bib32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0735-1097(01)01106-8","article-title":"Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation","volume":"37","author":"Mazur","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib33","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0735-1097(98)00495-1","article-title":"Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications","volume":"32","author":"Credner","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib34","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.103.16.2066","article-title":"Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"103","author":"Exner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.93.4.753","article-title":"Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators","volume":"93","author":"Villacastin","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/eupc.2000.0104","article-title":"Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias","volume":"2","author":"Greene","year":"2000","journal-title":"Europace"},{"key":"10.1016\/j.hfc.2010.12.003_bib37","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehl276","article-title":"Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial","volume":"27","author":"Hohnloser","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2010.12.003_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCULATIONAHA.106.618421","article-title":"Effect of amiodarone and sotalol on ventricular defibrillation threshold: the Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) trial","volume":"114","author":"Hohnloser","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-5273(99)00055-8","article-title":"Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment","volume":"69","author":"Kuhlkamp","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib40","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0735-1097(98)00160-0","article-title":"Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold","volume":"31","author":"Zhou","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.106.637397","article-title":"Follow-up defibrillator testing for antiarrhythmic drugs: probability and uncertainty","volume":"114","author":"Wood","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.86.4.1206","article-title":"Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study","volume":"86","author":"Epstein","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-8703(87)90300-0","article-title":"Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements","volume":"114","author":"Fain","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2010.12.003_bib44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1540-8167.2000.tb00043.x","article-title":"Effect of chronic amiodarone therapy on defibrillation energy requirements in humans","volume":"11","author":"Pelosi","year":"2000","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1009879708404","article-title":"Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation","volume":"3","author":"Qi","year":"1999","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.109.858027","article-title":"Droendarone","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0735-1097(00)00733-6","article-title":"Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance","volume":"36","author":"Bansch","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib48","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1540-8159.2004.00702.x","article-title":"Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center","volume":"27","author":"Rajawat","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib49","doi-asserted-by":"crossref","first-page":"39D","DOI":"10.1016\/S0002-9149(02)03378-7","article-title":"Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues","volume":"91","author":"Wolbrette","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib51","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199902183400707","article-title":"Radio-frequency ablation as treatment for\u00a0cardiac arrhythmias","volume":"340","author":"Morady","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2010.12.003_bib54","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2010.12.003_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1026205028816","article-title":"Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia","volume":"9","author":"Weinstock","year":"2003","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hfc.2010.12.003_bib56","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1056\/NEJMe0706860","article-title":"Ablation after ICD implantation\u2013bridging the gap between promise and practice","volume":"357","author":"Estes","year":"2007","journal-title":"N\u00a0Engl J Med"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713610001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713610001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T14:59:03Z","timestamp":1543762743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713610001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1551713610001339"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2010.12.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}